Brief: Eiko Lifesciences Approved Right Entitlement Ratio Of 2 Share For Every 3 Shares Held
30/06/2023 14:42
June 30 (Reuters) - Eiko Lifesciences Ltd EIKO.BO :
* APPROVED RIGHT ENTITLEMENT RATIO OF 2 SHARE FOR EVERY 3
SHARES
HELD
* APPROVED RIGHT ISSUE PRICE OF 45 RUPEES PER SHARE
Source text for Eikon: ID:nBSE4QrjDq
Further company coverage: EIKO.BO
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Eiko Lifesciences
See all newsBrief: Eiko Lifesciences To Buy 51% Stake In SSM Formulations
Brief: Eiko Lifesciences Ltd Says Buys 51% Of SSM Formulations
Brief: Eiko Lifesciences Says Proposal To Raise Funds Via Equity, Convertible Securities, Warrants
India's Eiko Lifesciences jumps on foray into logistics business
Brief: Eiko Lifesciences Announces Strategic Diversification Into Logistics And Container Management